English
简体中文
繁體中文
客服热线:400-1616-289
登录
注册
会议论文
Sintilimab versus pembrolizumab in monotherapy or combination with chemotherapy as first-line therapy for advanced non-small cell lung cancer: Results from phase 2, randomized clinical trial (CTONG1901).
Liu, Si-Yang Maggie; Zhou, Qing; Yan, Hong-Hong; Bin, Gan; Yang, Ming-Yi; Deng, Jia-Yi; Tu, Hai-Yan; Zhang, Xuchao; Su, Jian; Yang, Jinji; Wu, Yi-Long
广东省人民医院; 1
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)
2022-6-1
6
被引
21
阅读
引用
收藏
分享
相关
加载中…
文献加载失败,请重试
重试